British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy
Isogenica has licensed its synthetic llama antibody library to Maverick Therapeutics, which develops cancer T-cell…
Isogenica has licensed its synthetic llama antibody library to Maverick Therapeutics, which develops cancer T-cell…
Some people have already decided to take a leap of faith by cryogenically freezing themselves,…
Global Bioenergies and Butagaz will collaborate to develop and incorporate renewable energy sources into France's…
Biosyntia wants to reduce time and expenses in vitamin production by engineering microorganisms. Watch Hans…
At Labiotech Refresh we had the opportunity to chat with Marc Delcourt, founder and CEO…
Producing fuels and chemicals from CO2 and light has long been a dream of Biotech,…
Removing CO2 from the atmosphere could help with climate change, and there's now a new…
Evolva is licensing the CRISPR patents of Emmanuelle Charpentier, in a deal with holding company…
Genetic engineering can make food healthier, improve nutrition and reduce environmental impact. To demonstrate its…
The iGEM 2016 results are in! The world's largest synthetic biology competition took place in Boston from…
Replacing petroleum-based products with biobased equivalents is the Holy Grail of the bioeconomy. What are…
The assimilation of the human race has begun! A Star Trek nightmare is coming true,…